Literature DB >> 20065678

Assessment of radiation damage-the need for a multiparametric and integrative approach with the help of both clinical and biological dosimetry.

Armin Riecke1, Christian G Ruf, Viktor Meineke.   

Abstract

Accidental exposure to ionizing radiation leads to damage on different levels of the biological organization of an organism. Depending on exposure conditions, such as the nature of radiation, time and affected organs and organ systems, the clinical endpoint of radiation damage and the resulting acute and chronic radiation syndromes may vary to a great extent. Exposure situations range from purely localized radiation scenarios and partial-body exposures to whole-body exposures. Therefore, clinical pictures vary from localized radiation injuries up to the extreme situation of radiation-induced multi-organ involvement and failure requiring immediate, intensive, and interdisciplinary medical treatment. These totally different and complex clinical situations not only appear most different in clinical diagnostic and therapeutic aspects, but also, due to different levels of underlying biological damage, biological indicators of effects may vary to a wide extent. This fact means that an exact assessment of the extent of radiation damage within individual patients can only be performed when taking into consideration clinical as well as different biological indicators. Among the clinical indicators, routine laboratory parameters such as blood counts and the documentation of clinical signs and symptoms (using such methods as the METREPOL system) are the key parameters, but dicentric assay, the gold standard for biological dosimetry, and other methods under development, such as the gamma-H2AX focus assay or gene expression analysis of radiosensitive genes, must also be taken into account. Each method provides best results in different situations, or, in other words, there are methods that work better in a specific exposure condition or at a given time of examination (e.g., time after exposure) than others. Some methods show results immediately; others require days to weeks until results are available for clinical decision-making. Therefore, to provide the best basis for triage and planning and to provide medical treatment after accidental radiation exposure, different and independent diagnostic procedures integrating all clinical aspects as well as different biological indicators have to be applied. This multiparametric approach has been suggested after recent radiation accidents but needs to be adopted and standardized worldwide. A new integrative concept is shown and discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20065678     DOI: 10.1097/HP.0b013e3181b97306

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  14 in total

1.  Citrulline as a Biomarker in the Murine Total-Body Irradiation Model: Correlation of Circulating and Tissue Citrulline to Small Intestine Epithelial Histopathology.

Authors:  Jace W Jones; Gregory Tudor; Fei Li; Yan Tong; Barry Katz; Ann M Farese; Thomas J MacVittie; Catherine Booth; Maureen A Kane
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

2.  Evaluating the Special Needs of The Military for Radiation Biodosimetry for Tactical Warfare Against Deployed Troops: Comparing Military to Civilian Needs for Biodosimetry Methods.

Authors:  Ann Barry Flood; Arif N Ali; Holly K Boyle; Gaixin Du; Victoria A Satinsky; Steven G Swarts; Benjamin B Williams; Eugene Demidenko; Wilson Schreiber; Harold M Swartz
Journal:  Health Phys       Date:  2016-08       Impact factor: 1.316

3.  Serum microRNAs are early indicators of survival after radiation-induced hematopoietic injury.

Authors:  Sanket S Acharya; Wojciech Fendler; Jacqueline Watson; Abigail Hamilton; Yunfeng Pan; Emily Gaudiano; Patryk Moskwa; Payel Bhanja; Subhrajit Saha; Chandan Guha; Kalindi Parmar; Dipanjan Chowdhury
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

4.  A Framework for Comparative Evaluation of Dosimetric Methods to Triage a Large Population Following a Radiological Event.

Authors:  Ann Barry Flood; Roberto J Nicolalde; Eugene Demidenko; Benjamin B Williams; Alla Shapiro; Albert L Wiley; Harold M Swartz
Journal:  Radiat Meas       Date:  2011-09-01       Impact factor: 1.898

5.  Advances in a framework to compare bio-dosimetry methods for triage in large-scale radiation events.

Authors:  Ann Barry Flood; Holly K Boyle; Gaixin Du; Eugene Demidenko; Roberto J Nicolalde; Benjamin B Williams; Harold M Swartz
Journal:  Radiat Prot Dosimetry       Date:  2014-04-11       Impact factor: 0.972

6.  Targeted Metabolomics of Nonhuman Primate Serum after Exposure to Ionizing Radiation: Potential Tools for High-throughput Biodosimetry.

Authors:  Evan L Pannkuk; Evagelia C Laiakis; Simon Authier; Karen Wong; Albert J Fornace
Journal:  RSC Adv       Date:  2016-05-20       Impact factor: 3.361

7.  Citrulline as a Biomarker in the Non-human Primate Total- and Partial-body Irradiation Models: Correlation of Circulating Citrulline to Acute and Prolonged Gastrointestinal Injury.

Authors:  Jace W Jones; Alexander Bennett; Claire L Carter; Gregory Tudor; Kim G Hankey; Ann M Farese; Catherine Booth; Thomas J MacVittie; Maureen A Kane
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

8.  A critical assessment of biodosimetry methods for large-scale incidents.

Authors:  Harold M Swartz; Ann Barry Flood; Robert M Gougelet; Michael E Rea; Roberto J Nicolalde; Benjamin B Williams
Journal:  Health Phys       Date:  2010-02       Impact factor: 1.316

9.  Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations.

Authors:  Julie M Sullivan; Pataje G S Prasanna; Marcy B Grace; Lynne K Wathen; Rodney L Wallace; John F Koerner; C Norman Coleman
Journal:  Health Phys       Date:  2013-12       Impact factor: 1.316

10.  System for Scoring Severity of Acute Radiation Syndrome Response in Rhesus Macaques (Macaca mulatta).

Authors:  Gregory L King; David J Sandgren; Jennifer M Mitchell; David L Bolduc; William F Blakely
Journal:  Comp Med       Date:  2018-10-10       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.